FocusCORONAVIRUS

HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19

See allHide authors and affiliations

Science Immunology  08 May 2020:
Vol. 5, Issue 47, eabc5367
DOI: 10.1126/sciimmunol.abc5367

Article Information

vol. 5 no. 47

PubMed: 
Published By: 
History: 
  • Received April 29, 2020
  • Accepted May 5, 2020
  • .

Article Versions

Author Information

  1. Francesca Romana Spinelli1,
  2. Fabrizio Conti1 and
  3. Massimo Gadina2,*
  1. 1Sapienza Università di Roma, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari—Reumatologia, Rome, Italy.
  2. 2Translational Immunology Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA.
  1. *Corresponding author. Email: gadinama{at}mail.nih.gov

Altmetric

Article usage

Article usage: May 2020 to November 2020

AbstractFullPdf
May 2020558106863468
Jun 20201462783971
Jul 2020501697619
Aug 2020898342119
Sep 202011056140
Oct 202010444631
Nov 202010192325

Stay Connected to Science Immunology